Global Personalized Gene Therapy Treatment Market Performance Report: Global Trends 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the personalized gene therapy treatment market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Personalized Gene Therapy Treatment Market’s size between 2026 and 2030?
The personalized gene therapy treatment market has seen remarkable growth in recent years. It is anticipated to increase from $8.38 billion in 2025 to $10.11 billion in 2026, showcasing a compound annual growth rate (CAGR) of 20.7%. The expansion observed historically can be attributed to several factors, including the increasing prevalence of genetic disorders, advancements in genomic sequencing technologies, early clinical success of targeted gene therapies, the expansion of specialized gene therapy research centers, and increasing investment in precision medicine.
The personalized gene therapy treatment market size is projected to experience substantial growth in the upcoming years. It is foreseen to expand to $21.23 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 20.4%. This expansion over the forecast period stems from factors such as increasing regulatory approvals for personalized gene therapies, a heightened demand for customized oncology treatments, the broadening of gene therapy manufacturing capabilities, greater integration of artificial intelligence in therapy design, and the rising adoption of pharmacogenomics-guided treatments. Noteworthy trends during this period encompass the growing acceptance of gene editing-based therapies, an increased utilization of personalized treatment protocols, the expanding integration of companion diagnostics, the development of viral and non-viral vector platforms, and a more pronounced focus on precision oncology applications.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28293&type=smp
Which Drivers Are Shaping Strategic Decisions In The Personalized Gene Therapy Treatment Market?
An anticipated expansion in the personalized gene therapy treatment market is primarily fueled by the increasing occurrence of genetic disorders. These conditions arise from DNA abnormalities that disrupt normal physiological processes. The prevalence of genetic disorders is on the rise due to increasing parental age, as older reproductive cells carry a higher risk of mutations that can be inherited by offspring. Personalized gene therapy addresses genetic disorders by precisely correcting the defective genes responsible for the condition, tailoring treatment to an individual’s genetic makeup, which enhances efficacy and reduces side effects. For instance, in October 2024, according to Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, approximately 11,148 cystic fibrosis (a genetic disorder) patients were registered in 2022, and this figure increased to 11,318 in 2023, indicating a 1.5% year-over-year growth in patient registrations. Consequently, the escalating incidence of genetic disorders is driving the growth of the personalized gene therapy treatment market.
What Segment Categories Are Covered In The Personalized Gene Therapy Treatment Market?
The personalized gene therapy treatment market covered in this report is segmented –
1) By Therapy: Targeted Treatments, Pharmacogenomics
2) By Vector Type: Viral, Non-Viral
3) By Distribution Channel: Hospitals, Clinics, Home Administration, Other Distribution Channels
4) By Application: Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications
Subsegments:
1) By Targeted Treatments: Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy
2) By Pharmacogenomics: Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction
What Trends Are Reshaping The Dynamics Of The Personalized Gene Therapy Treatment Market?
Leading companies in the personalized gene therapy treatment market are concentrating on forming strategic collaborations to broaden their technological capacities and deliver innovative therapies to patients more effectively. Strategic partnerships involve cooperative arrangements between organizations, aimed at utilizing each other’s strengths and resources for mutual development and competitive advantage, while also distributing risks and benefits. For example, in May 2025, Aldevron, a US-based firm specializing in DNA, RNA, and protein manufacturing, partnered with Integrated DNA Technologies, a US-based supplier of genomics solutions, to create the world’s first mRNA-based personalized CRISPR therapy. This therapy was designed to treat an infant afflicted with urea cycle disorder (UCD), a rare and life-threatening genetic condition. This N of 1 therapy was developed and made available in just six months, achieved by creating a custom guide RNA, an mRNA-encoded base editor, off-target safety services, and a clinically validated lipid nanoparticle delivery system. The development of this therapy represents a substantial breakthrough in personalized in vivo base-editing treatments.
Which Leading Companies Dominate The Personalized Gene Therapy Treatment Market Share?
Major companies operating in the personalized gene therapy treatment market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation
Access The Complete Report For Deeper Market Insights:
How Does The Personalized Gene Therapy Treatment Market Perform Across Major Global Regions?
North America was the largest region in the personalized gene therapy treatment market in 2025. The regions covered in the personalized gene therapy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Personalized Gene Therapy Treatment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28293&type=smp
Browse Through More Reports Similar to the Global Personalized Gene Therapy Treatment Market 2026, By The Business Research Company
Genes Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Nucleic Acid Based Gene Therapy Market Report 2026
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
